BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7685496)

  • 1. Treosulphan, myleran and butadiene: similarities and differences.
    Ashby J
    Mutat Res; 1993 Jul; 300(2):77-8. PubMed ID: 7685496
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutagenicity of the human carcinogen treosulphan in Salmonella.
    Zeiger E; Pagano DA
    Environ Mol Mutagen; 1989; 13(4):343-6. PubMed ID: 2544419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenicity of the human carcinogen treosulphan, and its hydrolysis product, dl-1,2:3,4-diepoxybutane in mammalian cells.
    Zhu S; Zeiger E
    Environ Mol Mutagen; 1993; 21(1):95-9. PubMed ID: 8419160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo doses of butadiene epoxides as estimated from in vitro enzyme kinetics by using cob(I)alamin and measured hemoglobin adducts: an inter-species extrapolation approach.
    Motwani HV; Törnqvist M
    Toxicol Appl Pharmacol; 2014 Dec; 281(3):276-84. PubMed ID: 25448046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations induced by 1,3-butadiene metabolites, butadiene diolepoxide, and 1,2,3,4-diepoxybutane at the Hprt locus in CHO-K1 cells.
    Lee DH; Kim TH; Lee SY; Kim HJ; Rhee SK; Yoon B; Pfeifer GP; Lee CS
    Mol Cells; 2002 Dec; 14(3):411-9. PubMed ID: 12521305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,3-Butadiene and its epoxides induce sister-chromatid exchanges in human lymphocytes in vitro.
    Sasiadek M; Norppa H; Sorsa M
    Mutat Res; 1991 Oct; 261(2):117-21. PubMed ID: 1922154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinogenicity of 1,3-butadiene.
    Melnick RL; Huff J; Matanoski GM
    Lancet; 1992 Sep; 340(8821):724-5. PubMed ID: 1355815
    [No Abstract]   [Full Text] [Related]  

  • 8. Sister-chromatid exchanges induced by 1.3-butadiene and its epoxides in CHO cells.
    Sasiadek M; Järventaus H; Sorsa M
    Mutat Res; 1991 May; 263(1):47-50. PubMed ID: 2034239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Species differences in DNA damage by butadiene: role of diepoxybutane.
    Jelitto B; Vangala RR; Laib RJ
    Arch Toxicol Suppl; 1989; 13():246-9. PubMed ID: 2774939
    [No Abstract]   [Full Text] [Related]  

  • 10. Toxicology and epidemiology of 1,3-butadiene.
    Himmelstein MW; Acquavella JF; Recio L; Medinsky MA; Bond JA
    Crit Rev Toxicol; 1997 Jan; 27(1):1-108. PubMed ID: 9115622
    [No Abstract]   [Full Text] [Related]  

  • 11. 1,3-butadiene: cancer, mutations, and adducts. Part I: Carcinogenicity of 1,2,3,4-diepoxybutane.
    Henderson RF; Barr EB; Belinsky SA; Benson JM; Hahn FF; Ménache MG
    Res Rep Health Eff Inst; 2000 Mar; (92):11-43; discussion 45-8. PubMed ID: 10925838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sister-chromatid exchanges, glutathione S-transferase theta deletion and cytogenetic sensitivity to diepoxybutane in lymphocytes from butadiene monomer production workers.
    Kelsey KT; Wiencke JK; Ward J; Bechtold W; Fajen J
    Mutat Res; 1995 Dec; 335(3):267-73. PubMed ID: 8524342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future research needs for non-cancer and cancer effects among populations exposed to 1,3-butadiene.
    Koppikar AM
    Toxicology; 1996 Oct; 113(1-3):203-9. PubMed ID: 8901899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the genetic and related effects of 1,3-butadiene in rodents and humans.
    Jackson MA; Stack HF; Rice JM; Waters MD
    Mutat Res; 2000 Oct; 463(3):181-213. PubMed ID: 11018742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treosulphan.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1981 May; 26():341-7. PubMed ID: 6944265
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk assessment of butadiene in ambient air; the approach used in the UK.
    Fielder RJ
    Toxicology; 1996 Oct; 113(1-3):221-5. PubMed ID: 8901901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemoglobin adducts and micronuclei in rodents after treatment with isoprene monoxide or butadiene monoxide.
    Fred C; Grawé J; Törnqvist M
    Mutat Res; 2005 Aug; 585(1-2):21-32. PubMed ID: 15925539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic and germ cell effects in rats and mice after treatment with 1,3-butadiene and its metabolites, 1,2-epoxybutene and 1,2,3,4-diepoxybutane.
    Anderson D; Dobrzyńka MM; Jackson LI; Yu TW; Brinkworth MH
    Mutat Res; 1997 Jul; 391(3):233-42. PubMed ID: 9268048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenicity of stereochemical configurations of 1,3-butadiene epoxy metabolites in human cells.
    Meng RQ; Hackfeld LC; Hedge RP; Wisse LA; Redetzke DL; Walker VE;
    Res Rep Health Eff Inst; 2010 Jun; (150):1-34; discussion 35-41. PubMed ID: 20853577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenicity of 1,3-butadiene and its epoxide metabolites in human TK6 cells and in splenic T cells isolated from exposed B6C3F1 mice.
    Cochrane JE; Skopek TR
    IARC Sci Publ; 1993; (127):195-204. PubMed ID: 8070866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.